Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUKsix: Panobinostat + VTD for Relapsed/Refractory Multiple Myeloma
NCT02145715Phase 2Unknown
- Start
- Jan 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of panobinostat in multiple myeloma (MM). Status: unknown.
02
Drugs
panobinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02145715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145715.